Clinical Genetics – Richard Rosenquist Brandell's research group

We investigate genetic disorders on a molecular level in a translational research setting in order to understand disease mechanisms, apply new knowledge in genetic diagnostics, improve prognosis assessment and develop new treatment strategies. Our research group consists of four teams and our main interests are hematological malignancies, with a particular focus on chronic lymphocytic leukemia, lymphoma and pediatric acute lymphoblastic leukemia, metabolic bone disorders, and cancer genetics.

Part of the Department of Molecular Medicine and Surgery
Richard Rosenquist Brandell
Richard Rosenquist Brandell.

Richard Rosenquist Brandell

Richard Rosenquist Brandell is Professor of Clinical Genetics and research group leader for Clinical Genetics at the Department of Molecular Medicine and Surgery.

News Clinical Genetics

Our Research Areas

We investigate genetic disorders at a molecular level in a translational research setting in order to understand disease mechanisms, apply new knowledge in genetic diagnostics, improve prognosis assessment and develop new treatment strategies. Our research group consists of six teams and our main interests are hematological malignancies, with a particular focus on chronic lymphocytic leukemia, lymphomas and pediatric acute lymphoblastic leukemia, metabolic bone disorders, and cancer genetics.

Research teams

Members and contact

Group leader

All members of the group

Genomic Medicine Sweden

Genomic Medicine Sweden (GMS) is a national infrastructure in precision medicine with a vision to implement precision medicine into clinical settings and strengthen the collaboration between Swedish healthcare, research and life-science industry. GMS is comprised of seven regions with university hospitals and universities with a medical faculty. Together with patient organizations, healthcare providers, universities and industry, GMS aims to translate genomic innovation, based on advanced next-generation sequencing technologies, enabling greater precision in the diagnosis, treatment and management of patients with rare disease, cancer and infectious diseases.

Links

Genomic Medicine Sweden